BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28179317)

  • 1. Hypofractionated Palliative Radiotherapy with Concurrent Radiosensitizing Chemotherapy for Advanced Head and Neck Cancer Using the "QUAD-SHOT Regimen".
    Gamez ME; Agarwal M; Hu KS; Lukens JN; Harrison LB
    Anticancer Res; 2017 Feb; 37(2):685-691. PubMed ID: 28179317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer.
    Corry J; Peters LJ; Costa ID; Milner AD; Fawns H; Rischin D; Porceddu S
    Radiother Oncol; 2005 Nov; 77(2):137-42. PubMed ID: 16260054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclical hypofractionated radiotherapy also known as "QUAD Shot" alone using intensity-modulated radiotherapy for squamous cell carcinoma of the parotid gland in an 85-year-old patient with multiple comorbidities.
    Kil WJ; Camphausen K
    Head Neck; 2017 Apr; 39(4):E55-E60. PubMed ID: 28170130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated palliative radiotherapy for advanced head and neck cancer: the IHF2SQ regimen.
    Monnier L; Touboul E; Durdux C; Lang P; St Guily JL; Huguet F
    Head Neck; 2013 Dec; 35(12):1683-8. PubMed ID: 23359352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 "QUAD shot" regimen for incurable head and neck cancer.
    Toya R; Saito T; Yamaguchi K; Matsuyama T; Watakabe T; Matsumoto T; Yoshida R; Hirosue A; Murakami D; Orita Y; Nakayama H; Oya N
    Radiat Oncol; 2020 May; 15(1):123. PubMed ID: 32460865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclical hypofractionated radiotherapy technique for palliative treatment of locally advanced head and neck cancer: institutional experience and review of palliative regimens.
    Finnegan TS; Bhatt NH; Shaughnessy JN; Perez C; Redman R; Silverman C; Bumpous J; Potts K; Dunlap NE
    J Community Support Oncol; 2016 Jan; 14(1):29-36. PubMed ID: 26870840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.
    Prestwich RJ; Öksüz DÇ; Dyker K; Coyle C; Şen M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e237-43. PubMed ID: 21620580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer.
    Hughes RT; Gebeyehu RR; Kalada JM; Lycan TW; Frizzell BA; Kinney RD; D'Agostino RB; Bunch PM; Triozzi P; Zhang W; Furdui CM; Porosnicu M
    Future Oncol; 2023 Jul; 19(22):1523-1534. PubMed ID: 37199326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot.
    Ma J; Lok BH; Zong J; Gutiontov SI; Cai X; Bell AC; Shcherba M; Xiao H; Sherman EJ; Tsai CJ; Riaz N; McBride SM; Cahlon O; Lee NY
    Int J Part Ther; 2018; 4(4):10-19. PubMed ID: 30246055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 0-7-21 hypofractionated palliative radiotherapy: an effective treatment for advanced head and neck cancers.
    Nguyen NT; Doerwald-Munoz L; Zhang H; Kim DH; Sagar S; Wright JR; Hodson DI
    Br J Radiol; 2015 May; 88(1049):20140646. PubMed ID: 25694259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers.
    Lok BH; Jiang G; Gutiontov S; Lanning RM; Sridhara S; Sherman EJ; Tsai CJ; McBride SM; Riaz N; Lee NY
    Oral Oncol; 2015 Oct; 51(10):957-62. PubMed ID: 26282714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of split-course hypofractionated palliative radiotherapy in head and neck cancer.
    Kancherla KN; Oksuz DC; Prestwich RJ; Fosker C; Dyker KE; Coyle CC; Sen M
    Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):141-8. PubMed ID: 20934860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation Therapy Oncology Group 8502 "QUAD shot" regimen using volumetric modulated arc therapy for incurable head and neck cancer.
    Toya R; Fukugawa Y; Saito T; Matsuyama T; Yoshida R; Murakami D; Orita Y; Nakayama H; Oya N
    Oral Oncol; 2024 Apr; 151():106752. PubMed ID: 38518555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated hypofractionation (OCTA SHOT): Palliative radiation schedule in advanced head and neck carcinoma.
    Jakhar SL; Purohit R; Solanki A; Murali P; Kothari T; Sharma N; Kumar HS
    J Cancer Res Ther; 2017; 13(6):943-946. PubMed ID: 29237955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
    Choe KS; Haraf DJ; Solanki A; Cohen EE; Seiwert TY; Stenson KM; Blair EA; Portugal L; Villaflor VM; Witt ME; Vokes EE; Salama JK
    Cancer; 2011 Oct; 117(20):4671-8. PubMed ID: 21671479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction Chemotherapy and Sequential Concomitant Chemo-radiation in Locally Advanced Head and Neck Cancers: How Induction-phase Intensity and Treatment Breaks May Impact on Clinical Outcomes.
    Franco P; Potenza I; Schena M; Riva G; Pecorari G; Garzino Demo P; Fasolis M; Moretto F; Garzaro M; Di Muzio J; Melano M; Airoldi M; Ragona R; Rampino M; Ricardi U
    Anticancer Res; 2015 Nov; 35(11):6247-54. PubMed ID: 26504058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are oral cancers effectively palliated with radiotherapy? Outcomes of treatment with a modified QUAD SHOT regimen.
    Saha S; Mallick I; Mukherjee P; Chakraborty S; Bhattacharyya T; S MA; Achari RB; Chatterjee S
    Head Neck; 2024 Jun; 46(6):1270-1279. PubMed ID: 38528774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
    Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliation of pelvic and head and neck cancer with paclitaxel and a novel radiotherapy regimen.
    Carrascosa LA; Yashar CM; Paris KJ; Larocca RV; Faught SR; Spanos WJ
    J Palliat Med; 2007 Aug; 10(4):877-81. PubMed ID: 17803408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.